Total Holdings
79
Portfolio diversification across 79 positions
IBRN
(NYSEARCA)iShares Neuroscience and Healthcare ETF
$37.33-- (--)
Loading... - Market loading
IBRN ETF Holdings: iShares Neuroscience and Healthcare ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$5.61M
Total fund assets
Expense Ratio
0.47%
Annual management fee
Fund Issuer
BlackRock
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Dianthus Therapeutics, Inc. | Stock | 5.14% |
| 2 |  | Xenon Pharmaceuticals Inc | Stock | 5.09% |
| 3 |  | Alkermes plc | Stock | 4.77% |
| 4 |  | Praxis Precision Medicines, Inc | Stock | 4.77% |
| 5 |  | ACADIA Pharmaceuticals Inc. | Stock | 4.72% |
| 6 |  | Arrowhead Pharmaceuticals, Inc. | Stock | 4.69% |
| 7 |  | Scholar Rock Holding Corp | Stock | 4.59% |
| 8 |  | Neurocrine Biosciences, Inc. | Stock | 4.38% |
| 9 |  | PTC Therapeutics, Inc | Stock | 4.35% |
| 10 |  | Biogen Inc. | Stock | 4.26% |
| 11 |  | Axsome Therapeutics, Inc | Stock | 4.01% |
| 12 |  | argenx SE | Stock | 3.95% |
| 13 |  | Denali Therapeutics Inc. | Stock | 3.76% |
| 14 |  | Dyne Therapeutics, Inc. | Stock | 3.51% |
| 15 |  | Edgewise Therapeutics, Inc. | Stock | 3.31% |
| 16 |  | Supernus Pharmaceuticals, Inc | Stock | 2.75% |
| 17 |  | Axogen, Inc. | Stock | 2.27% |
| 18 | K KO:326030 | Sk Biopharmaceuticals Co Ltd | Stock | 2.19% |
| 19 | K KRX:326030 | SK Biopharmaceuticals Co., Ltd. | Stock | 2.16% |
| 20 |  | Biohaven Pharmaceutical Holding Co Ltd | Stock | 1.86% |
| 21 |  | Sarepta Therapeutics, Inc | Stock | 1.83% |
| 22 | H HLUNB.CO | H. LUNDBECK CLASS B | Stock | 1.82% |
| 23 | C CO:HLUN.B | H Lundbeck A/S | Stock | 1.80% |
| 24 | S STO:BIOA.B | BioArctic AB (publ) | Stock | 1.51% |
| 25 | S SWX:IDIA | Idorsia Ltd | Stock | 1.50% |
| 26 |  | Taysha Gene Therapies, Inc | Stock | 1.49% |
| 27 | A ASX:NEU | Neuren Pharmaceuticals Ltd | Stock | 1.41% |
| 28 | S ST:BIOA.B | BioArctic AB (publ) | Stock | 1.40% |
| 29 |  | Integra LifeSciences Holdings Corporation | Stock | 1.39% |
| 30 |  | Rapport Therapeutics, Inc. Common Stock | Stock | 1.20% |
| 31 |  | Capricor Therapeutics Inc | Stock | 1.05% |
| 32 |  | ANRO | Stock | 0.90% |
| 33 |  | Annexon Inc | Stock | 0.88% |
| 34 |  | Solid Biosciences Inc | Stock | 0.74% |
| 35 | E EPA:MEDCL | Medincell SA | Stock | 0.71% |
| 36 | S ST:DYVOX | Dynavox Group | Stock | 0.71% |
| 37 |  | LB Pharmaceuticals Inc Common Stock | Stock | 0.67% |
| 38 |  | Bright Minds Biosciences Inc | Stock | 0.59% |
| 39 |  | REGENXBIO Inc | Stock | 0.55% |
| 40 |  | Relmada Therapeutics, Inc | Stock | 0.53% |
| 41 |  | Design Therapeutics, Inc. Common Stock | Stock | 0.50% |
| 42 |  | CBLL | Stock | 0.49% |
| 43 |  | Neurogene Inc | Stock | 0.48% |
| 44 |  | Brainsway Ltd | Stock | 0.46% |
| 45 |  | Neuropace Inc | Stock | 0.45% |
| 46 |  | Benitec Biopharma Inc | Stock | 0.45% |
| 47 | T TSE:4588 | Oncolys Biopharma Inc | Stock | 0.44% |
| 48 |  | Ovid Therapeutics Inc | Stock | 0.43% |
| 49 |  | ClearPoint Neuro Inc | Stock | 0.42% |
| 50 |  | Prothena Corporation plc | Stock | 0.42% |
Frequently Asked Questions About iShares Neuroscience and Healthcare ETF Holdings
What are the top holdings in IBRN?
iShares Neuroscience and Healthcare ETF (IBRN) holds 79 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is IBRN's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review IBRN's holdings table to analyze concentration risk.
What is IBRN's sector allocation?
The Sector Allocation chart shows how IBRN distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does IBRN invest in?
IBRN's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is IBRN ETF?
IBRN's diversification can be assessed by reviewing its 79 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.